Trevi Therapeutics plans to launch two Phase 2 clinical trials testing Haduvio for chronic cough in people with idiopathic pulmonary fibrosis.| Pulmonary Fibrosis News
Enrollment is now complete in the CORAL clinical trial of nalbuphine ER, to be marketed as Haduvio, for IPF patients with chronic cough.| Pulmonary Fibrosis News
A Phase 2b clinical trial testing Haduvio for IPF cough reached 75% of targeted enrollment but is still recruiting patients in 10 countries.| Pulmonary Fibrosis News
September is Pulmonary Fibrosis Awareness Month, and advocates are hoping to call attention to the condition and interstitial lung diseases.| Pulmonary Fibrosis News
The inhaled NXP002 achieves significant levels in the lungs and lowers the production of scarring-promoting molecules, a study shows.| Pulmonary Fibrosis News
Columnist Ann Reynoso explains that she's using Ozempic to manage several health issues, but also to hopefully qualify for a lung transplant.| Pulmonary Fibrosis News
Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.| Pulmonary Fibrosis News
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis.| Pulmonary Fibrosis News
Category archive page for Columns.| Pulmonary Fibrosis News
Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.| Pulmonary Fibrosis News
